Gerald has many talents and has served the company well. But managing shareholder expectations has been difficult for him. I think it is appropriate AMBS has sought a professional firm to handle the PR and coordinate all of their communications to the media. They need to speak about their development with LymPro, MANF, and Eltoprazine in an accurate and consistent manner. With all that Gerald has on his plate, that was too much to ask of him.
I don't know that her arrival necessarily portends big news next week, but I think the next 6 months are going to be intense media months for AMBS, for several positive reasons.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links